Conference Coverage

AI-Identified Vascular Healing Can Predict Clinical Relapse in Ulcerative Colitis


 

FROM ECCO 2024

Still in the Early Stages

AI-assisted colonoscopy work is still at an early stage , said session co-moderator, Monika Ferlitsch, MD, head of Internal Medicine Department II, gastroenterology and hepatology, Evangelical Hospital, in Vienna, Austria.

We now have initial results, but “I suspect it will take 10-20 years for implementation into routine clinical practice,” she said.

The best outcome for our patients is to be able to predict response to therapy and recurrence rates, “and we see this is possible now with AI. But of course, we need more clinical data to support it,” Dr. Ferlitsch said.

Dr. Maeda and Dr. Ferlitsch have declared no financial disclosures.

A version of this article appeared on Medscape.com.

Pages

Next Article:

Novel Biotherapeutic to Be Tested in Ulcerative Colitis